Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « blockade »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
block < blockade < blockbuster  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 42.
[0-20] [0 - 20][0 - 42][20-40]
Ident.Authors (with country if any)Title
000012 (2005) Norihiro Nishimoto [Japon]Clinical studies in patients with Castleman’s disease, Crohn’s disease, and rheumatoid arthritis in Japan
000022 (2011) Leonid Gibiansky [États-Unis] ; Nicolas Frey [États-Unis]Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach
000023 (2009) Misato Hashizume [Japon] ; Yasushi Uchiyama [Japon] ; Naoto Horai [Japon] ; Naohisa Tomosugi [Japon] ; Masahiko Mihara [Japon]Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
000039 (2011) Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
000075 (2011) J. D. Alves [Portugal] ; A. Marinho [Portugal] ; M. J. Serra [Portugal]Tocilizumab: is there life beyond anti‐TNF blockade?
000080 (2012) M. Licht [Allemagne] ; U. Kyank [Allemagne] ; C. Kneitz [Allemagne]Therapierefraktäre Polyarthritis und Fieber
000091 (2012) Sooha Kim [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni]Interleukin-6 and cytochrome-P450, reason for concern?
000143 (2012) Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France]Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
000148 (2013) L. Naumann [Allemagne] ; E. Feist [Allemagne] ; G.-R. Burmester [Allemagne]Antizytokintherapie
000179 (2009) Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi [Japon] ; Tadamitsu KishimotoEvidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody
000194 (2007) M. Schneider [Allemagne]Exploring new territory: considering the future
000222 (2008) M. Aringer [Allemagne] ; E. Feierl [Autriche] ; J. Smolen [Autriche]Zytokinblockade – eine vielversprechende Therapieoption bei SLE
000245 (2012) M. Frosch [Allemagne] ; D. Holzinger [Allemagne] ; J. Roth [Allemagne]Systemische Verlaufsform der juvenilen idiopathischen Arthritis
000251 (2006) Chi Chiu Mok [Hong Kong]Biological therapies for rheumatoid arthritis: beyond TNF‐α blockade
000262 (2016) Peter Birner [Autriche] ; Susanne Heider [Autriche] ; Peter Petzelbauer [Autriche] ; Peter Wolf [Autriche] ; Christoph Kornauth [Autriche] ; Madeleine Kuroll [Autriche] ; Olaf Merkel [Autriche] ; Günter Steiner [Japon] ; Tadamitsu Kishimoto [Japon] ; Stefan Rose-John [Allemagne] ; Afschin Soleiman [Autriche] ; Richard Moriggl [Autriche] ; Lukas Kenner [Autriche]Interleukin‐6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus
000309 (2012) K. Yamamoto [Allemagne] ; S. Rose-John [Allemagne]Therapeutic Blockade of Interleukin‐6 in Chronic Inflammatory Disease
000416 (2013) M. Skwarek [Allemagne] ; B. Heschel [Allemagne] ; M. Winzer [Allemagne] ; M. Aringer [Allemagne]THU0112 Effects of inflammatory activity and therapeutic interleukin-6 receptor (IL-6R) blockade on IL-6R alpha expression and STAT3 phosphorylation in rheumatoid arthritis (RA)
000481 (2013) K. Fragiadaki [Grèce] ; K. Makrilakis [Grèce] ; J. Smith [Royaume-Uni] ; P. P. Sfikakis [Grèce] ; G. D. Kitas [Royaume-Uni]AB0316 Changes of adipokine serum levels after il-6 receptor blockade with tocilizumab in patients with rheumatoid arthritis
000543 (2013) Takayuki Sakurai [Japon] ; Ryo Takai [Japon] ; Heinrich Bürgin [Suisse] ; Akifumi Shioda [Japon] ; Yuichiro Sakamoto [Japon] ; Jun Amano [Japon] ; Hans Peter Grimm [Suisse] ; Wolfgang F. Richter [Suisse] ; Yoshinobu Higuchi [Japon] ; Shuichi Chiba [Japon] ; Akinori Kawamura [Japon] ; Masami Suzuki [Japon] ; Lutz Müller [Suisse]The Effects of Interleukin‐6 Signal Blockade on Immune System, Reproductive and Skeletal Development in Juvenile Mice
000595 (2013) Allan Thiolat [France] ; Jerome Biton [France] ; Luca Semerano [France] ; Yves-Marie Pers [France] ; Pierre Portales [France] ; Delphine Lemeiter [France] ; Patrice Decker [France] ; Christian Jorgensen [France] ; Marie-Christophe Boissier [France] ; Pascale Louis-Plence [France] ; Natacha Bessis [France]A3.10 IL-6 Receptor Blockade Enhances CD39+ Regulatory T-Cell Development in Rheumatoid Arthritis and in Experimental Arthritis
000664 (2011) E. Merlin [France] ; L. Berthomieu [France] ; C. Dauphin [France] ; J. L. Stéphan [France]Cardiac Tamponade in a Child With Systemic-Onset Juvenile Idiopathic Arthritis: Dramatic Improvement After Interleukin-1 Blockade by Anakinra

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "blockade" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "blockade" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    blockade
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021